India, Sanofi Pasteur Seek French Ruling On Tax Liability For Acquisition
This article was originally published in PharmAsia News
Executive Summary
India’s tax laws suggest Sanofi Pasteur might be subject to a $58 million charge for its majority acquisition of Indian drug-maker Shantha Biotechnics three years ago.